VOLUME 53 | NUMBER 6 | DECEMBER 2018
CostEffectiveness of a CommunityBased Diabetes Prevention Program with Participation Incentives for Medicaid Beneficiaries
Objective: To examine the costeffectiveness of a communitybased Diabetes Prevention Program (DPP) for Medicaid beneficiaries from the perspective of the health care sector.
Data Sources/Study Setting: A total of 847 Medicaid enrollees at high risk for type 2 diabetes participating in a communitybased DPP.
Study Design: Pre and post clinical outcome and cost data were used as inputs into a validated diabetes simulation model. The model was used to evaluate qualityadjusted life years (QALYs) and health care costs over a 40year time horizon from the perspective of the health care sector.
Data Collection/Extraction Methods: Clinical outcome and cost data were derived from a study examining the effect of financial incentives on weight loss.
Principal Findings: Study participants lost an average of 4.2 lb (p < .001) and increased highdensity lipoprotein cholesterol by 1.75 mg/dl (p = .002). Intervention costs, which included financial incentives for participation and weight loss, were $915 per participant. The incremental costeffectiveness ratio was estimated to be $14,011 per QALY but was sensitive to the time horizon studied.
Conclusions: Widespread adoption of communitybased DPP has the potential to reduce diabetes and cardiovascularrelated morbidity and mortality for lowincome persons at high risk for diabetes and may be a costeffective investment for Medicaid programs.
Copyright© 2018, Health Research & Educational Trust. All rights reserved. Content Disclaimer
Health Research & Educational Trust, 155 North Wacker, 4th Floor Chicago, IL 60606 (312) 422.2600